What the FDA also knows.....
Sepsis is wildly
What the FDA also knows.....
<<There is a lot of uncertainty surrounding COVID-19, but what we do know is that COVID-19 can lead to sepsis. The World Health Organization declared COVID-19 a global health emergency, calling it an “unprecedented outbreak.” Millions of people have been diagnosed, and many remain in critical condition suffering from acute respiratory failure, septic shock, and/or multiple organ dysfunction and failure. These patients are treated in the ICU, where they are exposed to countless risk factors that can lead to secondary infections or co-infections, including exposure to numerous antimicrobial therapies, which are often unnecessary. >>
Sepsis is wildly contagious and wildly expensive to treat and re-admission costs the hospital out of pocket. Hospitals are the pillars of society, and exert tremendous influence on government agencies like the FDA. They have immense power to influence. My point is the FDA wants and needs a drug(s) like leron. They want to be the one who approves a world class fix. And I hope Mexico is hot on their tail soon.
I admit I sold some CYDY at $2.99 and bought TTOO at $1, they do testing for various things including Covid, Sepsis in hrs vs days, and soon will be doing LYME. I also own a small position in Contrafect, they have the only new anti-biologic drug in 50 years, a direct lytic agent (lysin) that attacks the cell walls (paraphrased) and not likely to become resistant.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...
Continue Reading
Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...
Continue Reading
California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...
Continue Reading
Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...
Continue Reading
Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...
Continue Reading
Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...
Continue Reading
Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...
Continue Reading
Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...
Continue Reading
Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....
Continue Reading
Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Threat Intelligence Analysis Push Security has taken a significant leap in revolutionizing cybersecurity with its newly launched verified stolen credentials detection capability. Designed specifically for security teams, this innovative feature aims to reshape how identity threats are tackled, ensuring a more effective response to compromised credentials....
Continue Reading
Vera Bradley's Upcoming Earnings Announcement Vera Bradley (NASDAQ: VRA) is preparing to unveil its quarterly earnings soon. Investors are eager to gain insights into the company’s performance and the future outlook. Earnings Expectations Currently, analysts predict that Vera Bradley will post an earnings per share (EPS) of $-0.11. This information is pivotal as...
Continue Reading
Anticipating ATRenew's Earnings Report ATRenew (NYSE:RERE) is preparing to release its latest quarterly earnings report soon. Investors are eagerly awaiting news that could impact the stock's performance positively. Financial analysts are estimating that ATRenew will report an earnings per share (EPS) of $0.05 in the upcoming release. The atmosphere surrounding the...
Continue Reading
AutoZone’s Short Interest: A Telling Shift AutoZone (NYSE: AZO) is in the spotlight as its short percent of float sees a notable uptick. That’s right—an increase of 3.2% has landed the current shorted shares tally at 436 thousand. If you’re doing the math, that makes up about 2.9% of all trading shares floating around. Notably, with current trading volumes in...
Continue Reading
Berenberg stood firm on its Hold rating for Novo Nordisk (NYSE: NVO) shares, driven by nagging concerns about the Phase 3 clinical trial results for CagriSema, a therapy that could have turned the tides. With the current price target stuck at DKK975.00, investor nerves are frayed over how negative outcomes might play out in the market. The whispers on the desk suggest...
Continue Reading